Development and validation of a machine learning model to predict the daily risk of febrile neutropenia in patients with AML undergoing chemotherapy

Anna Mervaala-Muroke; Laura Toivanen; Pia Ettala; Riikka Räty; Mikko Keränen; Oscar Brück
Current Treatment Options in Rheumatology · Springer Nature · 2026-11-13

Аннотация

Communications Medicine, Published online: 13 November 2026; doi:10.1038/s43856-026-02001-x Development and validation of a machine learning model to predict the daily risk of febrile neutropenia in patients with AML undergoing chemotherapy

Читать у издателя →

Похожие статьи